GLI GLI Quality Tool
GLI Quality Tool — Version 2.0

A Practical Vendor Evaluation Method for TB Laboratory Reagents

Selecting a reagent supplier for a tuberculosis laboratory is a quality decision, a clinical decision, and an operational decision. The lowest quoted price may become expensive if a product produces unreliable results, arrives late, requires unfamiliar equipment, or cannot be replaced during a supply interruption.

A structured vendor evaluation process gives laboratory managers a consistent way to compare manufacturers and distributors. It also creates documented evidence for procurement decisions, internal reviews, accreditation activities, and future reassessment. The method should work for molecular testing reagents, culture media, staining materials, susceptibility testing supplies, extraction kits, controls, and other products used in the diagnostic workflow.

The process should fit the laboratory’s quality management system rather than operate as a separate purchasing exercise. The GLI Quality Tool’s Phase 1 guidance can help a laboratory establish the basic quality practices, responsibilities, and documentation needed before formal supplier assessment begins.

Define The Laboratory’s Requirements

Begin by describing exactly what the laboratory needs from a reagent or consumable. The specification should include the intended test, specimen types, target organisms or resistance markers, expected testing volume, storage conditions, shelf life, required controls, compatible instruments, and relevant regulatory or national program requirements. Avoid specifications that name a preferred brand unless there is a justified technical reason to do so.

Performance requirements should be measurable. For example, the laboratory may require a molecular assay to include an internal control, have documented analytical sensitivity, provide clear invalid-result procedures, and remain stable for a defined period after delivery. A culture medium may need a particular formulation, lot-release documentation, sterility assurance, and acceptable growth performance with local reference strains.

Operational requirements deserve equal attention. A suitable vendor should offer reliable delivery schedules, responsive technical support, certificates of analysis, safety data sheets, training materials, and a process for handling complaints or product recalls. If the laboratory operates in a setting with unreliable electricity or difficult transport routes, packaging and temperature-control performance should be included in the specification.

Assess Supplier And Product Risk

Risk-based evaluation prevents the laboratory from applying the same level of scrutiny to every purchase. A reagent that directly determines rifampicin resistance may require a more detailed assessment than a general cleaning product. Consider the effect of failure on patient management, the likelihood of product failure, the availability of alternatives, and the time required to detect a problem.

Product risk can be divided into several categories. Technical risk includes poor sensitivity, cross-reactivity, contamination, unstable controls, or incompatibility with existing instruments. Supply risk includes long lead times, short remaining shelf life, customs delays, limited production capacity, and dependence on a single distributor. Compliance risk covers missing licenses, unclear labeling, inadequate documentation, or failure to meet applicable standards.

Supplier risk should also be examined. A vendor with a strong product may still be unsuitable if it cannot provide traceability or has no local service arrangement. Request evidence such as quality certifications, product registration, manufacturer information, batch records, recall procedures, customer references, and performance data from laboratories using similar methods. Verify important claims rather than accepting promotional material as proof.

Create A Scored Evaluation Protocol

A written protocol makes vendor comparisons transparent. Assign evaluation categories, scoring definitions, and weights before reviewing quotations. A five-point scale can work well when each score has a clear meaning: one might indicate unacceptable evidence, three acceptable evidence with limitations, and five strong, independently verified evidence.

Suggested categories include technical performance, quality documentation, supply continuity, cost, technical support, logistics, regulatory status, and experience with tuberculosis testing. Weight the categories according to risk. For a critical diagnostic reagent, analytical performance and quality assurance should carry more weight than minor differences in packaging or purchase price.

The protocol should distinguish mandatory requirements from preferred features. A vendor that lacks a required regulatory document or cannot demonstrate product traceability should be excluded, even if its price is attractive. Preferred features can help separate vendors that meet all essential requirements, such as local stock, online order tracking, extended warranty support, or consignment inventory.

Use the same questions and evidence requirements for every candidate. Keep quotations, completed assessment forms, supporting documents, meeting notes, and final approval records in a controlled location. This documentation allows another reviewer to understand why a supplier was selected and helps prevent informal preferences from shaping the outcome.

Verify Performance Before Routine Use

Document review is important, but laboratory testing provides the strongest evidence that a new reagent fits the intended workflow. Establish a verification plan before the product arrives. Define the number and type of specimens, comparison method, acceptance criteria, staff responsible, required controls, and process for investigating discordant results.

For a molecular assay, verification may examine agreement with an established method, invalid rates, contamination events, control performance, and ease of interpretation. For culture or microscopy reagents, the plan may assess growth, staining quality, contamination, reproducibility, and performance with known positive and negative materials. The evaluation should reflect the actual patient population and operating conditions as closely as practical.

Check packaging and delivery at receipt. Record the supplier, product name, catalog number, lot number, quantity, expiry date, shipping temperature where relevant, and condition of the shipment. Quarantine materials that arrive damaged, mislabeled, contaminated, or outside the required temperature range until a responsible person decides whether they can be accepted.

A new product should not enter routine testing until authorized personnel have reviewed the verification results. If changes affect procedures, instruments, quality control, biosafety, or reporting, update the relevant standard operating procedures and train staff. Retain the verification report with the procurement and quality records.

Compare Vendors Using Evidence

A scoring matrix can make a complex decision easier to review. The example below is adaptable; laboratories should change the weights and thresholds to match their test menu and risk profile.

Evaluation area Weight Evidence to request Example acceptance criterion
Analytical and clinical performance 25% Instructions for use, validation data, independent evaluations Meets predefined sensitivity, specificity, or agreement targets
Quality and traceability 20% Certificates, lot records, complaint and recall procedures Complete records available for every delivered lot
Supply continuity 15% Stock information, lead times, production and distribution details Routine orders arrive within the laboratory’s required window
Technical support 10% Support contacts, training plan, response commitments Qualified assistance available during operating hours
Logistics and storage 10% Packaging details, temperature requirements, shipping history Product arrives intact and within specified conditions
Regulatory and safety status 10% Registration, labeling, safety data, manufacturer details Required approvals and safety documentation are current
Total cost of ownership 10% Quotation, freight, equipment, waste, training costs Cost remains within the approved budget without hidden charges

Price should be calculated as total cost of ownership rather than unit price alone. Include freight, customs, cold-chain fees, calibration, instrument rental, controls, accessories, waste disposal, staff training, and the cost of repeat testing caused by invalid or failed results. A slightly higher purchase price may represent better value when it reduces disruption and repeat work.

When scores are close, use a documented secondary review. Ask whether one supplier has a more dependable local distribution network, a stronger contingency plan, or better experience supporting laboratories with similar workloads. A final decision should be approved by designated laboratory, procurement, and quality personnel rather than by a single buyer.

Monitor The Supplier After Approval

Vendor qualification is a continuing activity. Establish performance indicators and review them at defined intervals, such as every six or twelve months, and whenever a serious problem occurs. Useful indicators include on-time delivery, order completeness, remaining shelf life, rejected lots, complaint response time, product failures, corrective actions, and unexpected price changes.

Staff should know how to report reagent problems. A complaint record should describe the product and lot, date received, storage history, observed issue, testing impact, immediate containment, communication with the supplier, and final resolution. Where appropriate, retain affected materials for investigation and notify the relevant national or institutional authority.

The supplier should be reassessed after major changes, including a new manufacturer, formulation, packaging, distributor, instrument platform, or regulatory status. The laboratory should also maintain a backup plan for critical reagents. This may involve a second qualified vendor, minimum stock levels, an approved alternative method, or an agreement with a nearby reference laboratory.

Continual improvement depends on using these records. The GLI Quality Tool’s Phase 4 resources are relevant when the laboratory is reviewing performance trends, addressing recurring supplier problems, and strengthening its quality system over time. A vendor review should lead to practical action, whether that means renewing approval, requesting corrective action, increasing safety stock, or beginning a new qualification process.

Practical Recommendations For Implementation

A small laboratory can begin with a simple controlled form and expand it as its procurement system matures. The essential point is to make requirements, evidence, decision authority, and follow-up visible to everyone involved.

A consistent process also improves communication with vendors. When suppliers receive clear specifications and measurable service expectations, they can respond more accurately and the laboratory can identify gaps early. Keep the method proportional to the laboratory’s resources, but never omit evidence for products that directly influence tuberculosis diagnosis or drug-resistance decisions.

Put the method into the laboratory’s quality documents, train relevant staff, and apply it to the next reagent purchase as a pilot. Review the results after the first procurement cycle, refine the scoring criteria, and use supplier performance data to build a dependable, evidence-based purchasing system.